Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_PAD,AGRP,Agouti-related protein,Inverse variance weighted,2,1.43 [1.34-1.53],6.5795345704736e-28,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CXCL13,C-X-C motif chemokine 13,Inverse variance weighted,2,1.37 [1.29-1.47],8.49214622003429e-21,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NPY,Pro-neuropeptide Y,Inverse variance weighted,2,1.32 [1.24-1.41],4.02502253595655e-17,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,1.28 [1.2-1.36],2.54810596587282e-14,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,2,1.26 [1.19-1.34],6.88813948473161e-14,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,2,0.79 [0.74-0.84],1.5234082496196e-13,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL23,C-C motif chemokine 23,Inverse variance weighted,2,1.26 [1.19-1.34],2.90395087164432e-13,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,2,1.25 [1.18-1.34],1.04805335578228e-12,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,2,1.22 [1.15-1.29],4.19863697549479e-12,trans
Chapter IX Diseases of the circulatory system,I9_PAD,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,2,1.25 [1.17-1.33],6.56686228882902e-12,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,2,1.23 [1.15-1.31],2.35022805581117e-10,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,2,1.22 [1.14-1.3],1.1849263644127e-09,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL16,C-C motif chemokine 16,Inverse variance weighted,2,1.17 [1.11-1.24],4.07503881191488e-09,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LGALS4,Galectin-4,Inverse variance weighted,2,1.19 [1.12-1.26],1.47597376314169e-08,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RTBDN,Retbindin,Inverse variance weighted,2,1.21 [1.13-1.29],1.51701663672933e-08,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.19 [1.12-1.27],1.66850574203262e-07,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VWC2,Brorin,Inverse variance weighted,2,1.17 [1.1-1.24],1.87837749813386e-07,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GCG,Pro-glucagon,Inverse variance weighted,2,1.2 [1.12-1.28],2.15113247568884e-07,trans
Chapter IX Diseases of the circulatory system,I9_PAD,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,2,1.18 [1.11-1.26],2.19971695099998e-07,trans
Chapter IX Diseases of the circulatory system,I9_PAD,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,2,1.18 [1.11-1.26],4.04911231154715e-07,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LGALS9,Galectin-9,Inverse variance weighted,2,1.16 [1.09-1.23],9.69216198160602e-07,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,2,0.88 [0.84-0.93],1.37117315010685e-06,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,2,1.19 [1.11-1.28],1.64150824203856e-06,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,2,1.17 [1.1-1.24],1.9947302144945e-06,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,2,1.16 [1.09-1.24],4.95110327981386e-06,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,2,1.15 [1.08-1.22],6.27222423037903e-06,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RNASE4,Ribonuclease 4,Inverse variance weighted,2,1.16 [1.09-1.23],7.1364418846578e-06,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SPON1,Spondin-1,Inverse variance weighted,2,1.15 [1.08-1.22],8.3365543277365e-06,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,2,1.12 [1.07-1.18],1.00278716953624e-05,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CHRDL1,Chordin-like protein 1,Inverse variance weighted,2,1.14 [1.07-1.21],1.6748748355071e-05,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PENK,Proenkephalin-A,Inverse variance weighted,2,1.15 [1.08-1.22],2.88212541289267e-05,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ANG,Angiogenin,Inverse variance weighted,2,1.13 [1.07-1.2],3.49485014839568e-05,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,1.15 [1.07-1.23],4.17304712117353e-05,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,2,1.15 [1.08-1.23],4.28057909338322e-05,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,2,1.13 [1.06-1.19],0.000103083457689547,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,2,1.14 [1.07-1.21],0.000116184273852525,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,2,1.13 [1.06-1.21],0.000126596505469493,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,2,1.13 [1.06-1.21],0.000127534480763014,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MRC1,Macrophage mannose receptor 1,Inverse variance weighted,2,1.13 [1.06-1.2],0.000131994293594557,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SERPINB8,Serpin B8,Inverse variance weighted,2,1.11 [1.05-1.17],0.000136068339810427,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DPT,Dermatopontin,Inverse variance weighted,2,1.12 [1.05-1.18],0.000184425556461651,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,2,1.12 [1.05-1.18],0.000193060768022017,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRSS2,Trypsin-2,Inverse variance weighted,2,1.13 [1.06-1.21],0.000197785362926174,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,2,1.13 [1.06-1.21],0.000206643948849972,trans
Chapter IX Diseases of the circulatory system,I9_PAD,REN,Renin,Inverse variance weighted,2,1.12 [1.05-1.2],0.000298496786031983,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,2,1.13 [1.06-1.2],0.000345862318194681,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,2,1.13 [1.06-1.21],0.000381554960680961,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.12 [1.05-1.2],0.000399352376255384,trans
Chapter IX Diseases of the circulatory system,I9_PAD,INHBB,Inhibin beta B chain,Inverse variance weighted,2,1.12 [1.05-1.19],0.000403556172049939,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CRH,Corticoliberin,Inverse variance weighted,2,1.23 [1.09-1.37],0.000446778825346127,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.12 [1.05-1.2],0.000512608605012863,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,2,1.11 [1.05-1.18],0.000626292942629983,trans
Chapter IX Diseases of the circulatory system,I9_PAD,COLEC12,Collectin-12,Inverse variance weighted,2,1.11 [1.05-1.18],0.000654224368489814,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KLK4,Kallikrein-4,Inverse variance weighted,2,1.1 [1.04-1.15],0.000679444158497009,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,2,1.11 [1.05-1.19],0.000789989023856215,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCN5,CCN family member 5,Inverse variance weighted,2,1.11 [1.04-1.18],0.000800070030191942,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MLN,Promotilin,Inverse variance weighted,2,1.11 [1.05-1.18],0.000806773086907232,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SERPINF1,Pigment epithelium-derived factor,Inverse variance weighted,2,1.11 [1.05-1.19],0.000828832714299257,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD300E,CMRF35-like molecule 2,Inverse variance weighted,2,1.11 [1.04-1.18],0.000853472102407401,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,2,0.9 [0.84-0.96],0.00105117739241544,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD207,C-type lectin domain family 4 member K,Inverse variance weighted,2,1.11 [1.04-1.18],0.00107592917965797,trans
Chapter IX Diseases of the circulatory system,I9_PAD,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,2,1.11 [1.04-1.19],0.001134938547958,trans
Chapter IX Diseases of the circulatory system,I9_PAD,OSM,Oncostatin-M,Inverse variance weighted,2,1.12 [1.04-1.19],0.00119533492869417,trans
Chapter IX Diseases of the circulatory system,I9_PAD,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,2,1.11 [1.04-1.19],0.00123054643817892,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1.12 [1.04-1.2],0.0015164105891372,trans
Chapter IX Diseases of the circulatory system,I9_PAD,WNT9A,Protein Wnt-9a,Inverse variance weighted,2,0.91 [0.85-0.96],0.00154681972076801,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.1 [1.04-1.16],0.00171783749952022,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,2,1.11 [1.04-1.19],0.00173836515984646,trans
Chapter IX Diseases of the circulatory system,I9_PAD,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,2,1.09 [1.03-1.15],0.00189538886791503,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HYOU1,Hypoxia up-regulated protein 1,Inverse variance weighted,2,1.11 [1.04-1.18],0.0020721416217413,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HSPB6,Heat shock protein beta-6,Inverse variance weighted,2,1.11 [1.04-1.19],0.00218460253314642,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL11,Eotaxin,Inverse variance weighted,2,1.1 [1.03-1.17],0.00236498018952965,trans
Chapter IX Diseases of the circulatory system,I9_PAD,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,0.91 [0.85-0.97],0.00262444500662904,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,Inverse variance weighted,2,1.11 [1.04-1.18],0.0026389738985488,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LETM1,Mitochondrial proton/calcium exchanger protein,Inverse variance weighted,2,1.11 [1.04-1.18],0.00288604589220322,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CST3,Cystatin-C,Inverse variance weighted,2,1.1 [1.03-1.17],0.00291223211916892,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GOLM2,Protein GOLM2,Inverse variance weighted,2,1.1 [1.03-1.18],0.00301801341873525,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,2,1.09 [1.03-1.16],0.00308917703826814,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,2,1.07 [1.02-1.13],0.0031138357440006,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CSTB,Cystatin-B,Inverse variance weighted,2,1.09 [1.03-1.15],0.00317666123960882,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.92 [0.87-0.97],0.00323244686516409,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FGA,Fibrinogen alpha chain,Inverse variance weighted,2,1.15 [1.05-1.26],0.00328584042927546,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,2,1.1 [1.03-1.17],0.00335728444513459,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,2,1.1 [1.03-1.17],0.00341710727845114,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL22,C-C motif chemokine 22,Inverse variance weighted,2,1.16 [1.05-1.28],0.00341773505994509,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CALCA,Calcitonin,Inverse variance weighted,2,1.12 [1.04-1.21],0.00344633237960783,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ROBO1,Roundabout homolog 1,Inverse variance weighted,2,1.1 [1.03-1.17],0.00358663524140456,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,2,1.1 [1.03-1.17],0.0039842951198118,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NPPC,C-type natriuretic peptide,Inverse variance weighted,2,1.09 [1.03-1.16],0.00411204511271243,trans
Chapter IX Diseases of the circulatory system,I9_PAD,AMBP,Protein AMBP,Inverse variance weighted,2,1.1 [1.03-1.17],0.00425818055407862,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,1.1 [1.03-1.17],0.00445651185412309,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LGALS3,Galectin-3,Inverse variance weighted,2,1.08 [1.03-1.15],0.00474655174389363,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRSS8,Prostasin,Inverse variance weighted,2,1.09 [1.03-1.16],0.00511783371842844,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.09 [1.03-1.16],0.00524294823838803,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FSTL3,Follistatin-related protein 3,Inverse variance weighted,2,1.09 [1.03-1.17],0.00538625882098593,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,2,1.09 [1.03-1.16],0.0054133383141865,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,2,1.1 [1.03-1.17],0.00551689427915287,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,2,1.08 [1.02-1.13],0.00568773494369797,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,2,1.09 [1.02-1.15],0.00580359023550247,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,2,1.1 [1.03-1.17],0.00602236048644109,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,2,1.09 [1.03-1.17],0.00608909135465091,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HNMT,Histamine N-methyltransferase,Inverse variance weighted,2,1.08 [1.02-1.15],0.00619196516572523,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CGREF1,Cell growth regulator with EF hand domain protein 1,Inverse variance weighted,2,1.08 [1.02-1.15],0.00623797993310192,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PGF,Placenta growth factor,Inverse variance weighted,2,1.09 [1.02-1.15],0.00657029638711432,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL7,C-C motif chemokine 7,Inverse variance weighted,2,1.09 [1.02-1.17],0.00667108484873876,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DKK4,Dickkopf-related protein 4,Inverse variance weighted,2,1.09 [1.02-1.17],0.00702022472461046,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL17C,Interleukin-17C,Inverse variance weighted,2,1.1 [1.02-1.17],0.00723860015213941,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,2,1.1 [1.02-1.17],0.00778638891986777,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CHGB,Secretogranin-1,Inverse variance weighted,2,1.08 [1.02-1.15],0.00782002259535903,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,2,1.09 [1.02-1.17],0.00846016637448693,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,2,1.09 [1.02-1.17],0.00875342149327498,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,2,1.09 [1.02-1.16],0.00914796309376524,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CALB1,Calbindin,Inverse variance weighted,2,1.09 [1.02-1.16],0.00929245501438157,trans
Chapter IX Diseases of the circulatory system,I9_PAD,XG,Glycoprotein Xg,Inverse variance weighted,2,1.07 [1.02-1.12],0.00930580963552062,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRELP,Prolargin,Inverse variance weighted,2,1.08 [1.02-1.15],0.00934143441276188,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,2,1.09 [1.02-1.16],0.00940886778735076,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,2,1.1 [1.02-1.18],0.0107588528621353,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ATP6AP2,Renin receptor,Inverse variance weighted,2,1.1 [1.02-1.18],0.010821123244291,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,2,1.07 [1.02-1.13],0.0108337693186736,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD40,Tumor necrosis factor receptor superfamily member 5,Inverse variance weighted,2,1.09 [1.02-1.16],0.0108916854424619,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCG2,Secretogranin-2,Inverse variance weighted,2,1.11 [1.02-1.2],0.011286213959293,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,1.09 [1.02-1.16],0.0123560289960767,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RNASE6,Ribonuclease K6,Inverse variance weighted,2,1.08 [1.02-1.15],0.0125042211656347,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.08 [1.02-1.16],0.0126380756407886,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NRP2,Neuropilin-2,Inverse variance weighted,2,1.08 [1.02-1.15],0.0132962484346384,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BCAN,Brevican core protein,Inverse variance weighted,2,1.08 [1.02-1.16],0.0133996362207175,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MMP3,Stromelysin-1,Inverse variance weighted,2,0.94 [0.9-0.99],0.0139967387784346,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ZBTB17,Zinc finger and BTB domain-containing protein 17,Inverse variance weighted,2,1.09 [1.02-1.16],0.014072287575349,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TGFBR3,Transforming growth factor beta receptor type 3,Inverse variance weighted,2,1.09 [1.02-1.17],0.0141629671479881,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ITGA5,Integrin alpha-5,Inverse variance weighted,2,1.08 [1.02-1.16],0.0142652276028149,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,2,1.09 [1.02-1.17],0.0148747444554715,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CA6,Carbonic anhydrase 6,Inverse variance weighted,2,1.07 [1.01-1.13],0.015527151421617,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,2,1.08 [1.01-1.15],0.0162926589086028,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,2,1.08 [1.01-1.15],0.0165813239090639,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,2,1.08 [1.01-1.16],0.0175191985668316,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LBP,Lipopolysaccharide-binding protein,Inverse variance weighted,2,0.93 [0.88-0.99],0.0175696881881805,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,1.08 [1.01-1.15],0.0178882441026707,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EFNA4,Ephrin-A4,Inverse variance weighted,2,1.08 [1.01-1.16],0.0183410087124922,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,2,1.08 [1.01-1.15],0.0186859414586032,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,2,1.08 [1.01-1.15],0.019295675372781,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MSMB,Beta-microseminoprotein,Inverse variance weighted,2,1.06 [1.01-1.1],0.0194511894608484,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DPY30,Protein dpy-30 homolog,Inverse variance weighted,2,1.08 [1.01-1.16],0.0196091207800143,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MATN2,Matrilin-2,Inverse variance weighted,2,1.08 [1.01-1.14],0.0202150336849236,trans
Chapter IX Diseases of the circulatory system,I9_PAD,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.08 [1.01-1.15],0.0212466253157857,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,2,1.07 [1.01-1.13],0.0215455036061937,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,1.1 [1.01-1.2],0.0221703369100259,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,1.08 [1.01-1.15],0.0223941097736131,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,2,1.07 [1.01-1.14],0.0225412704625812,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,1.08 [1.01-1.15],0.02304732151585,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HJV,Hemojuvelin,Inverse variance weighted,2,1.1 [1.01-1.2],0.0237663243809002,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,2,1.08 [1.01-1.15],0.0245864771258915,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,2,1.07 [1.01-1.13],0.0248301372354905,trans
Chapter IX Diseases of the circulatory system,I9_PAD,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.08 [1.01-1.15],0.0248487271092929,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD163,Scavenger receptor cysteine-rich type 1 protein M130,Inverse variance weighted,2,1.07 [1.01-1.14],0.025118835199321,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.08 [1.01-1.15],0.0251966075082821,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PLXNB2,Plexin-B2,Inverse variance weighted,2,1.08 [1.01-1.15],0.0259276282882883,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,2,1.1 [1.01-1.2],0.0259342377870415,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD27,CD27 antigen,Inverse variance weighted,2,1.08 [1.01-1.15],0.0267810729861968,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,2,1.1 [1.01-1.19],0.0269679449551374,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SPON2,Spondin-2,Inverse variance weighted,2,0.93 [0.87-0.99],0.0280070325645949,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NECTIN4,Nectin-4,Inverse variance weighted,2,1.07 [1.01-1.15],0.0291462952911201,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MUC13,Mucin-13,Inverse variance weighted,2,1.08 [1.01-1.15],0.0295945288370048,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,2,1.09 [1.01-1.18],0.031045219465152,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,2,0.93 [0.88-0.99],0.0319285431900137,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD59,CD59 glycoprotein,Inverse variance weighted,2,1.07 [1.01-1.14],0.0319396243933569,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.07 [1.01-1.14],0.03240737648885,trans
Chapter IX Diseases of the circulatory system,I9_PAD,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,2,1.07 [1.01-1.15],0.0324099349035939,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,2,1.07 [1.01-1.14],0.0334666399239819,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,2,1.07 [1.01-1.13],0.0336019315242498,trans
Chapter IX Diseases of the circulatory system,I9_PAD,XCL1,Lymphotactin,Inverse variance weighted,2,1.06 [1-1.13],0.0339520347268893,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,2,1.07 [1-1.13],0.0339585521924313,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FAM3B,Protein FAM3B,Inverse variance weighted,2,1.07 [1-1.13],0.0357398524242867,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRRT3,Proline-rich transmembrane protein 3,Inverse variance weighted,2,1.07 [1-1.15],0.0365319370035808,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,2,1.13 [1.01-1.28],0.0372481794199034,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,2,1.07 [1-1.14],0.0374748138856094,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,2,1.07 [1-1.14],0.0377628281180385,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,2,1.07 [1-1.14],0.0379810730489485,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,2,1.07 [1-1.14],0.0388922637888502,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IFNLR1,Interferon lambda receptor 1,Inverse variance weighted,2,1.09 [1-1.18],0.0409262302361643,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RETN,Resistin,Inverse variance weighted,2,1.07 [1-1.14],0.0415173552439146,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Inverse variance weighted,2,1.07 [1-1.14],0.0417314125864655,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,2,1.1 [1-1.2],0.0420757868306266,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,2,1.06 [1-1.12],0.0449985747531638,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,2,1.07 [1-1.13],0.0450658464468145,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,2,1.07 [1-1.14],0.046002176530845,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CANT1,Soluble calcium-activated nucleotidase 1,Inverse variance weighted,2,1.07 [1-1.14],0.0460865868370476,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,2,1.1 [1-1.21],0.0472904851140552,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,2,1.06 [1-1.11],0.0482083330220127,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,2,1.07 [1-1.14],0.048322318942066,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DLL1,Delta-like protein 1,Inverse variance weighted,2,1.1 [1-1.2],0.0485922477291292,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HEG1,Protein HEG homolog 1,Inverse variance weighted,2,1.13 [1-1.28],0.0486357129486202,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,2,1.07 [1-1.14],0.0489213835804975,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,2,1.07 [1-1.14],0.0493788114704913,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADA2,Adenosine deaminase 2,Inverse variance weighted,2,1.07 [1-1.14],0.0494411944383408,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HYAL1,Hyaluronidase-1,Inverse variance weighted,2,1.1 [1-1.21],0.0518905904565748,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,2,1.09 [1-1.18],0.0540333009599186,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL15,C-C motif chemokine 15,Inverse variance weighted,2,1.08 [1-1.17],0.0542436156829794,trans
Chapter IX Diseases of the circulatory system,I9_PAD,OGN,Mimecan,Inverse variance weighted,2,1.06 [1-1.12],0.054673576659548,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,2,1.06 [1-1.13],0.0554781250724312,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PALM,Paralemmin-1,Inverse variance weighted,2,1.07 [1-1.14],0.0556380316944082,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,2,1.07 [1-1.14],0.0559481346680786,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SDC1,Syndecan-1,Inverse variance weighted,2,1.06 [1-1.14],0.0569522603335831,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EPHB6,Ephrin type-B receptor 6,Inverse variance weighted,2,1.07 [1-1.14],0.0575847470552682,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CHGA,Chromogranin-A,Inverse variance weighted,2,0.94 [0.88-1],0.0576967374436229,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SNCG,Gamma-synuclein,Inverse variance weighted,2,1.06 [1-1.13],0.0624796863309243,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PCDH17,Protocadherin-17,Inverse variance weighted,2,1.07 [1-1.16],0.0638143493890594,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,2,1.06 [1-1.14],0.0639747983603987,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,2,1.08 [0.99-1.18],0.0661482497258235,trans
Chapter IX Diseases of the circulatory system,I9_PAD,APOM,Apolipoprotein M,Inverse variance weighted,2,1.06 [1-1.14],0.0662037307513176,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MMP7,Matrilysin,Inverse variance weighted,2,1.14 [0.99-1.31],0.0664254737048608,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,1.06 [1-1.13],0.0677052473524449,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,2,1.06 [1-1.13],0.0681687665888742,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LGALS1,Galectin-1,Inverse variance weighted,2,1.06 [0.99-1.13],0.0710392901285147,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.06 [0.99-1.13],0.0721264188622915,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,2,1.08 [0.99-1.17],0.0732500208837875,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VAMP5,Vesicle-associated membrane protein 5,Inverse variance weighted,2,0.94 [0.88-1.01],0.0736074876534209,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL21,C-C motif chemokine 21,Inverse variance weighted,2,1.11 [0.99-1.23],0.0756788098110165,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRSS22,Brain-specific serine protease 4,Inverse variance weighted,2,1.06 [0.99-1.14],0.0765368449232497,trans
Chapter IX Diseases of the circulatory system,I9_PAD,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.07 [0.99-1.15],0.0766582501557367,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,2,1.06 [0.99-1.13],0.0773019932453876,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GRN,Progranulin,Inverse variance weighted,2,1.07 [0.99-1.15],0.077851348282651,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,1.06 [0.99-1.13],0.0812309433511426,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,2,1.05 [0.99-1.12],0.0816173136556791,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EFNA1,Ephrin-A1,Inverse variance weighted,2,1.07 [0.99-1.15],0.0826812616190104,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FCRLB,Fc receptor-like B,Inverse variance weighted,2,1.05 [0.99-1.11],0.0840247130153803,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,2,1.09 [0.99-1.2],0.0841239093471223,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,2,1.04 [0.99-1.09],0.0856808229882002,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,2,1.06 [0.99-1.13],0.0858974305660386,trans
Chapter IX Diseases of the circulatory system,I9_PAD,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,2,1.06 [0.99-1.13],0.0864134609340961,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,2,1.06 [0.99-1.13],0.087898510686226,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SLAMF8,SLAM family member 8,Inverse variance weighted,2,1.06 [0.99-1.12],0.0891016005590883,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NEFL,Neurofilament light polypeptide,Inverse variance weighted,2,1.05 [0.99-1.11],0.0898723510016911,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,2,1.06 [0.99-1.12],0.0930350648686387,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,2,1.06 [0.99-1.13],0.0932414072113793,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,2,1.05 [0.99-1.12],0.09348497712675,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CRELD2,Protein disulfide isomerase CRELD2,Inverse variance weighted,2,1.06 [0.99-1.12],0.0940186585761453,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EPO,Erythropoietin,Inverse variance weighted,2,1.06 [0.99-1.13],0.0955400653503078,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,2,1.06 [0.99-1.13],0.0973506248725761,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,2,1.04 [0.99-1.1],0.0993495239222258,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,2,1.04 [0.99-1.1],0.101469944964167,trans
Chapter IX Diseases of the circulatory system,I9_PAD,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,2,1.05 [0.99-1.11],0.105150887625457,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,2,1.05 [0.99-1.12],0.107916581619603,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,2,1.07 [0.99-1.16],0.108172572046769,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TCOF1,Treacle protein,Inverse variance weighted,2,1.06 [0.99-1.13],0.110778277618402,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EPHA1,Ephrin type-A receptor 1,Inverse variance weighted,2,1.05 [0.99-1.12],0.112597035324228,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ELN,Elastin,Inverse variance weighted,2,1.04 [0.99-1.09],0.114261965265618,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.05 [0.99-1.12],0.114393846894279,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,1.05 [0.99-1.13],0.114670113471701,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,1.05 [0.99-1.11],0.114942955902504,trans
Chapter IX Diseases of the circulatory system,I9_PAD,OCLN,Occludin,Inverse variance weighted,2,1.05 [0.99-1.12],0.11631068970217,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,2,1.05 [0.99-1.11],0.117609503898897,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,2,1.05 [0.99-1.12],0.118494770365128,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,2,1.05 [0.99-1.12],0.119709521720423,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CAPG,Macrophage-capping protein,Inverse variance weighted,2,1.04 [0.99-1.1],0.120946272239395,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,2,1.1 [0.98-1.23],0.121751478938565,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SIGLEC1,Sialoadhesin,Inverse variance weighted,2,1.05 [0.99-1.12],0.123271028460194,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LPO,Lactoperoxidase,Inverse variance weighted,2,1.05 [0.99-1.12],0.124956085222207,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.05 [0.99-1.13],0.125881391495364,trans
Chapter IX Diseases of the circulatory system,I9_PAD,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Inverse variance weighted,2,1.07 [0.98-1.16],0.127494968716141,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,2,1.05 [0.99-1.12],0.128460910236345,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SIT1,Signaling threshold-regulating transmembrane adapter 1,Inverse variance weighted,2,1.05 [0.98-1.13],0.130252793743687,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CPVL,Probable serine carboxypeptidase CPVL,Inverse variance weighted,2,1.04 [0.99-1.1],0.133176576132438,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,2,1.05 [0.98-1.12],0.133814425797271,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",Inverse variance weighted,2,1.05 [0.98-1.12],0.13474647132679,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RSPO1,R-spondin-1,Inverse variance weighted,2,1.05 [0.98-1.12],0.135220046204963,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,2,1.05 [0.98-1.12],0.136929339158483,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.05 [0.98-1.12],0.143045127582262,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CHAD,Chondroadherin,Inverse variance weighted,2,1.05 [0.98-1.12],0.14427423690022,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SEMA3F,Semaphorin-3F,Inverse variance weighted,2,1.05 [0.98-1.12],0.14644052118853,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FABP4,"Fatty acid-binding protein, adipocyte",Inverse variance weighted,2,1.05 [0.98-1.11],0.147403035093927,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,2,1.05 [0.98-1.12],0.14901496237207,trans
Chapter IX Diseases of the circulatory system,I9_PAD,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,2,1.05 [0.98-1.12],0.149236356689682,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,2,1.05 [0.98-1.12],0.150801189659697,trans
Chapter IX Diseases of the circulatory system,I9_PAD,F2R,Proteinase-activated receptor 1,Inverse variance weighted,2,1.05 [0.98-1.12],0.151281649991977,trans
Chapter IX Diseases of the circulatory system,I9_PAD,APOC1,Apolipoprotein C-I,Inverse variance weighted,2,0.96 [0.9-1.02],0.152167594809323,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HEPH,Hephaestin,Inverse variance weighted,2,1.05 [0.98-1.12],0.15285973904775,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,2,1.05 [0.98-1.12],0.153714264429779,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,2,1.05 [0.98-1.11],0.15386924898616,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IDUA,Alpha-L-iduronidase,Inverse variance weighted,2,1.04 [0.98-1.1],0.155272685995835,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,2,1.05 [0.98-1.12],0.160479778171231,trans
Chapter IX Diseases of the circulatory system,I9_PAD,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,2,1.06 [0.98-1.16],0.16053083709072,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NTRK3,NT-3 growth factor receptor,Inverse variance weighted,2,0.96 [0.9-1.02],0.162516611647481,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD99,CD99 antigen,Inverse variance weighted,2,1.04 [0.98-1.1],0.16421147264516,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Inverse variance weighted,2,0.93 [0.85-1.03],0.165619368586369,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,2,1.04 [0.98-1.11],0.165849740512157,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SPP1,Osteopontin,Inverse variance weighted,2,1.05 [0.98-1.12],0.166294382688947,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,2,1.06 [0.98-1.15],0.16694407602126,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL3,C-C motif chemokine 3,Inverse variance weighted,2,1.04 [0.98-1.11],0.169166603340501,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NFASC,Neurofascin,Inverse variance weighted,2,1.06 [0.98-1.14],0.169543609220183,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GDF15,Growth/differentiation factor 15,Inverse variance weighted,2,1.06 [0.98-1.14],0.170805765736929,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,2,1.04 [0.98-1.11],0.173977049143779,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL14,C-C motif chemokine 14,Inverse variance weighted,2,1.04 [0.98-1.11],0.175289943908673,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.04 [0.98-1.11],0.176052513946983,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,2,1.04 [0.98-1.11],0.176656107770239,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,2,1.05 [0.98-1.11],0.178565767420803,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,2,1.04 [0.98-1.11],0.179983705100295,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KLK11,Kallikrein-11,Inverse variance weighted,2,1.05 [0.98-1.13],0.180170524642459,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SHISA5,Protein shisa-5,Inverse variance weighted,2,1.04 [0.98-1.11],0.180681784905584,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PALM2,Paralemmin-2,Inverse variance weighted,2,1.04 [0.98-1.11],0.181309821582405,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,2,1.04 [0.98-1.09],0.181632838130675,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CTSO,Cathepsin O,Inverse variance weighted,2,1.04 [0.98-1.11],0.183065431676188,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KLK8,Kallikrein-8,Inverse variance weighted,2,1.04 [0.98-1.11],0.183305993092202,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL18,Interleukin-18,Inverse variance weighted,2,1.04 [0.98-1.11],0.184095524261682,trans
Chapter IX Diseases of the circulatory system,I9_PAD,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,0.96 [0.89-1.02],0.186941379221021,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Inverse variance weighted,2,1.04 [0.98-1.12],0.187845965242769,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,2,1.04 [0.98-1.11],0.193740474707732,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PGA4,Pepsin A-4,Inverse variance weighted,2,1.04 [0.98-1.11],0.196086798363139,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,2,1.04 [0.98-1.11],0.19641147127184,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DRAXIN,Draxin,Inverse variance weighted,2,1.04 [0.98-1.11],0.196580162349249,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Inverse variance weighted,2,1.06 [0.97-1.17],0.197012465145747,trans
Chapter IX Diseases of the circulatory system,I9_PAD,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,2,0.95 [0.89-1.03],0.198971068737665,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,2,1.04 [0.98-1.11],0.199120903507614,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HIP1R,Huntingtin-interacting protein 1-related protein,Inverse variance weighted,2,1.04 [0.98-1.11],0.199532545737824,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ANGPT2,Angiopoietin-2,Inverse variance weighted,2,1.04 [0.98-1.11],0.200736344396479,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CTSL,Cathepsin L1,Inverse variance weighted,2,1.04 [0.98-1.11],0.203508928125606,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LY96,Lymphocyte antigen 96,Inverse variance weighted,2,1.04 [0.98-1.11],0.203661017533204,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1.04 [0.98-1.11],0.203850549952399,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD48,CD48 antigen,Inverse variance weighted,2,1.04 [0.98-1.1],0.204604878862624,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,2,1.04 [0.98-1.11],0.205233932146372,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,2,1.06 [0.97-1.15],0.206842130788989,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,2,1.05 [0.97-1.12],0.211003530874152,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,2,1.04 [0.98-1.11],0.212165823234482,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ENAH,Protein enabled homolog,Inverse variance weighted,2,1.04 [0.98-1.12],0.213337780518022,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,2,1.04 [0.98-1.11],0.21530789638935,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VWF,von Willebrand factor,Inverse variance weighted,2,0.96 [0.9-1.02],0.215560431838252,trans
Chapter IX Diseases of the circulatory system,I9_PAD,REG1B,Lithostathine-1-beta,Inverse variance weighted,2,1.06 [0.97-1.17],0.216034333708102,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,2,1.04 [0.98-1.11],0.217377074640843,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RGMB,RGM domain family member B,Inverse variance weighted,2,1.04 [0.98-1.11],0.219209001730683,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD7,T-cell antigen CD7,Inverse variance weighted,2,1.04 [0.98-1.11],0.221418771358244,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FBLN2,Fibulin-2,Inverse variance weighted,2,1.04 [0.98-1.11],0.221746579333233,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,2,1.04 [0.98-1.11],0.221840375155482,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CDSN,Corneodesmosin,Inverse variance weighted,2,1.05 [0.97-1.13],0.221975827994765,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,2,1.03 [0.98-1.09],0.223410785725537,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DKK3,Dickkopf-related protein 3,Inverse variance weighted,2,1.07 [0.96-1.19],0.224419947836284,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCGN,Secretagogin,Inverse variance weighted,2,1.04 [0.97-1.11],0.224596852783785,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LAYN,Layilin,Inverse variance weighted,2,1.05 [0.97-1.14],0.225118436631954,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,2,1.07 [0.96-1.2],0.226252261787749,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,2,1.04 [0.98-1.1],0.227305741278584,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CRHBP,Corticotropin-releasing factor-binding protein,Inverse variance weighted,2,1.04 [0.98-1.1],0.229977707794267,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,2,1.04 [0.98-1.11],0.231970486870209,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DSC2,Desmocollin-2,Inverse variance weighted,2,1.05 [0.97-1.15],0.232232740802801,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,1.04 [0.97-1.11],0.232621333071805,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,2,1.03 [0.98-1.09],0.236061211639103,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,1.04 [0.97-1.11],0.237259732337008,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,2,1.04 [0.97-1.11],0.238997085956227,trans
Chapter IX Diseases of the circulatory system,I9_PAD,AREG,Amphiregulin,Inverse variance weighted,2,1.04 [0.97-1.11],0.241896834135736,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,2,1.04 [0.98-1.1],0.242461089364231,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC4A,C-type lectin domain family 4 member A,Inverse variance weighted,2,0.96 [0.9-1.03],0.243814207338872,trans
Chapter IX Diseases of the circulatory system,I9_PAD,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.06 [0.96-1.17],0.249462257120084,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CDH1,Cadherin-1,Inverse variance weighted,2,1.04 [0.97-1.11],0.250226150454105,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,2,1.03 [0.98-1.1],0.250708874454297,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CFD,Complement factor D,Inverse variance weighted,2,1.04 [0.97-1.11],0.255702951120798,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ALPP,"Alkaline phosphatase, placental type",Inverse variance weighted,2,1.04 [0.97-1.12],0.256186010877205,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC3B,Tetranectin,Inverse variance weighted,2,1.08 [0.95-1.23],0.256729008471887,trans
Chapter IX Diseases of the circulatory system,I9_PAD,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,2,1.04 [0.97-1.11],0.26133389286738,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VCAN,Versican core protein,Inverse variance weighted,2,1.04 [0.97-1.11],0.262222995767141,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,2,1.03 [0.97-1.1],0.262239442886826,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.04 [0.97-1.1],0.26250781161711,trans
Chapter IX Diseases of the circulatory system,I9_PAD,C7,Complement component C7,Inverse variance weighted,2,1.03 [0.97-1.1],0.26316975429939,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BTN2A1,Butyrophilin subfamily 2 member A1,Inverse variance weighted,2,1.04 [0.97-1.11],0.265941833204157,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,2,1.05 [0.97-1.13],0.2660964063375,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,2,1.04 [0.97-1.1],0.268804242627139,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,2,1.05 [0.96-1.15],0.269828834711612,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,1.04 [0.97-1.11],0.272903471151972,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PYY,Peptide YY,Inverse variance weighted,2,1.04 [0.97-1.11],0.274482961462925,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD276,CD276 antigen,Inverse variance weighted,2,1.03 [0.98-1.09],0.27451215770841,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,2,1.04 [0.97-1.11],0.274524819536114,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNC,Tenascin,Inverse variance weighted,2,0.97 [0.91-1.03],0.277187735700148,trans
Chapter IX Diseases of the circulatory system,I9_PAD,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,2,1.04 [0.97-1.12],0.279479111683947,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,2,1.03 [0.98-1.09],0.282243136978641,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,2,1.04 [0.97-1.11],0.282731901071909,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PTK7,Inactive tyrosine-protein kinase 7,Inverse variance weighted,2,0.96 [0.9-1.03],0.284153590022996,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RNASET2,Ribonuclease T2,Inverse variance weighted,2,1.04 [0.97-1.11],0.284158450810307,trans
Chapter IX Diseases of the circulatory system,I9_PAD,WFDC1,WAP four-disulfide core domain protein 1,Inverse variance weighted,2,1.04 [0.97-1.11],0.284163865368278,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GUCA2A,Guanylin,Inverse variance weighted,2,1.04 [0.97-1.11],0.284274731747756,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.96 [0.9-1.03],0.288615385978915,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FABP5,Fatty acid-binding protein 5,Inverse variance weighted,2,1.04 [0.97-1.11],0.293331161577941,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TMPRSS11D,Transmembrane protease serine 11D,Inverse variance weighted,2,1.04 [0.97-1.11],0.294184325464524,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,2,0.97 [0.91-1.03],0.295395846453757,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,2,1.03 [0.97-1.1],0.297227418993286,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,2,1.04 [0.97-1.11],0.298856906585752,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,2,1.03 [0.97-1.1],0.299206304630544,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.09 [0.93-1.27],0.301187621071096,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Inverse variance weighted,2,1.04 [0.97-1.11],0.301416169332108,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RTN4R,Reticulon-4 receptor,Inverse variance weighted,2,1.03 [0.97-1.1],0.303272256534541,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IMMT,MICOS complex subunit MIC60,Inverse variance weighted,2,1.03 [0.97-1.1],0.304364208128391,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PI3,Elafin,Inverse variance weighted,2,1.03 [0.97-1.1],0.30626876424458,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,2,0.96 [0.9-1.03],0.306569493933326,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NECTIN2,Nectin-2,Inverse variance weighted,2,1.03 [0.97-1.11],0.307179667939725,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRG2,Bone marrow proteoglycan,Inverse variance weighted,2,1.03 [0.97-1.1],0.307594308573629,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CTSS,Cathepsin S,Inverse variance weighted,2,1.04 [0.97-1.11],0.310570155889975,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ANXA5,Annexin A5,Inverse variance weighted,2,1.04 [0.96-1.12],0.316572025280593,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HGF,Hepatocyte growth factor,Inverse variance weighted,2,1.03 [0.97-1.1],0.321115650178238,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SEL1L,Protein sel-1 homolog 1,Inverse variance weighted,2,1.03 [0.97-1.11],0.321687883884413,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,2,1.03 [0.97-1.1],0.321719006870989,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,1.03 [0.97-1.1],0.324813009040753,trans
Chapter IX Diseases of the circulatory system,I9_PAD,UMOD,Uromodulin,Inverse variance weighted,2,0.98 [0.93-1.03],0.329441557736672,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,2,1.03 [0.97-1.1],0.331361552803866,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,Inverse variance weighted,2,1.03 [0.97-1.1],0.333541232514183,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,2,1.03 [0.97-1.09],0.336300087004969,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TFF3,Trefoil factor 3,Inverse variance weighted,2,1.03 [0.97-1.1],0.336767650144285,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,2,1.03 [0.97-1.08],0.33747017658846,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GSN,Gelsolin,Inverse variance weighted,2,1.03 [0.97-1.1],0.340215096518082,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NRP1,Neuropilin-1,Inverse variance weighted,2,1.03 [0.97-1.1],0.342946423485469,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD302,CD302 antigen,Inverse variance weighted,2,1.03 [0.97-1.1],0.343992742300626,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,Inverse variance weighted,2,1.03 [0.97-1.1],0.349318338864149,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LGMN,Legumain,Inverse variance weighted,2,1.04 [0.96-1.13],0.349406640187161,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BSG,Basigin,Inverse variance weighted,2,0.97 [0.91-1.03],0.356227503411099,trans
Chapter IX Diseases of the circulatory system,I9_PAD,AGRN,Agrin,Inverse variance weighted,2,1.03 [0.97-1.1],0.360723175513871,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EGFR,Epidermal growth factor receptor,Inverse variance weighted,2,0.97 [0.91-1.03],0.361274247515541,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,2,1.03 [0.97-1.1],0.365204743491667,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCN4B,Sodium channel subunit beta-4,Inverse variance weighted,2,1.03 [0.97-1.09],0.366241398407704,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TMSB10,Thymosin beta-10,Inverse variance weighted,2,1.05 [0.95-1.16],0.371112584583413,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,2,1.03 [0.96-1.1],0.374558205380373,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NCAN,Neurocan core protein,Inverse variance weighted,2,1.05 [0.94-1.18],0.375601188812205,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ABCA2,ATP-binding cassette sub-family A member 2,Inverse variance weighted,2,1.03 [0.96-1.1],0.381963972501429,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FOLR1,Folate receptor alpha,Inverse variance weighted,2,1.06 [0.94-1.19],0.383548103478513,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,2,1.03 [0.96-1.1],0.38413617639416,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,2,1.04 [0.95-1.14],0.386386221524963,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,2,1.03 [0.97-1.1],0.387046769335365,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL19,Interleukin-19,Inverse variance weighted,2,1.04 [0.95-1.13],0.389901508282809,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.03 [0.96-1.1],0.390687363703622,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PVR,Poliovirus receptor,Inverse variance weighted,2,0.98 [0.93-1.03],0.395310930308476,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ALCAM,CD166 antigen,Inverse variance weighted,2,1.03 [0.96-1.11],0.400582371329334,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NPPB,Natriuretic peptides B,Inverse variance weighted,2,1.03 [0.96-1.1],0.404597513568663,trans
Chapter IX Diseases of the circulatory system,I9_PAD,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,2,1.07 [0.91-1.27],0.4100413342777,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,2,1.05 [0.93-1.2],0.424478109921308,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,2,1.03 [0.96-1.09],0.428624148113326,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,2,1.02 [0.97-1.07],0.431657350214361,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD300C,CMRF35-like molecule 6,Inverse variance weighted,2,1.02 [0.96-1.09],0.432018292267657,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,2,1.03 [0.96-1.1],0.433748833924467,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCN4,CCN family member 4,Inverse variance weighted,2,1.02 [0.96-1.09],0.434025468300638,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TGOLN2,Trans-Golgi network integral membrane protein 2,Inverse variance weighted,2,1.02 [0.97-1.08],0.434449879363143,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FAS,Tumor necrosis factor receptor superfamily member 6,Inverse variance weighted,2,1.04 [0.94-1.15],0.435644265903722,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KLRD1,Natural killer cells antigen CD94,Inverse variance weighted,2,1.02 [0.96-1.09],0.43695735582125,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,2,1.04 [0.94-1.15],0.446625788716628,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CA9,Carbonic anhydrase 9,Inverse variance weighted,2,0.98 [0.91-1.04],0.448610091534957,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CDNF,Cerebral dopamine neurotrophic factor,Inverse variance weighted,2,1.03 [0.96-1.09],0.44944938920944,trans
Chapter IX Diseases of the circulatory system,I9_PAD,POF1B,Protein POF1B,Inverse variance weighted,2,0.97 [0.91-1.04],0.449971446973156,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NUCB2,Nucleobindin-2,Inverse variance weighted,2,1.02 [0.96-1.09],0.454603374241644,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DDR1,Epithelial discoidin domain-containing receptor 1,Inverse variance weighted,2,0.98 [0.91-1.04],0.454631870063184,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,2,1.02 [0.96-1.09],0.456962501497927,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,2,0.98 [0.93-1.04],0.45907614778889,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.02 [0.96-1.09],0.462129990841826,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,2,1.03 [0.95-1.12],0.462191505384457,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL15,Interleukin-15,Inverse variance weighted,2,0.97 [0.91-1.05],0.463609078316717,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RBP2,Retinol-binding protein 2,Inverse variance weighted,2,1.04 [0.94-1.15],0.464377504219265,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,2,0.98 [0.92-1.04],0.464820450763732,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MB,Myoglobin,Inverse variance weighted,2,1.02 [0.96-1.08],0.468322696412351,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TFF1,Trefoil factor 1,Inverse variance weighted,2,1.02 [0.96-1.09],0.47285481244066,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCARF1,Scavenger receptor class F member 1,Inverse variance weighted,2,1.02 [0.96-1.09],0.474989654294607,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CTSZ,Cathepsin Z,Inverse variance weighted,2,0.97 [0.91-1.05],0.477717277210505,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,2,1.02 [0.96-1.09],0.477879421513824,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TFRC,Transferrin receptor protein 1,Inverse variance weighted,2,1.03 [0.94-1.13],0.47842104815599,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FURIN,Furin,Inverse variance weighted,2,1.02 [0.96-1.09],0.481694907067996,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,2,1.02 [0.96-1.09],0.482706803162753,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CPM,Carboxypeptidase M,Inverse variance weighted,2,0.98 [0.92-1.04],0.484016561828154,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,2,0.98 [0.92-1.04],0.485022799367652,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCN3,CCN family member 3,Inverse variance weighted,2,1.02 [0.96-1.08],0.491408558670706,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DMP1,Dentin matrix acidic phosphoprotein 1,Inverse variance weighted,2,0.97 [0.91-1.05],0.491792118234381,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,2,1.04 [0.92-1.18],0.494205318474643,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,2,1.03 [0.95-1.12],0.496989342516799,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,2,1.04 [0.92-1.18],0.499183450295336,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BCAM,Basal cell adhesion molecule,Inverse variance weighted,2,1.02 [0.96-1.09],0.501397750226939,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,Inverse variance weighted,2,1.02 [0.96-1.09],0.503833812632318,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,2,1.02 [0.96-1.09],0.50447822852695,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KLRK1,NKG2-D type II integral membrane protein,Inverse variance weighted,2,0.98 [0.92-1.04],0.504673749058458,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD5L,CD5 antigen-like,Inverse variance weighted,2,1.02 [0.95-1.1],0.510538057551166,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ACTA2,"Actin, aortic smooth muscle",Inverse variance weighted,2,1.02 [0.96-1.08],0.515843626330116,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,2,0.97 [0.87-1.07],0.518511790569584,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,2,1.02 [0.96-1.08],0.5211953693262,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ITGAV,Integrin alpha-V,Inverse variance weighted,2,0.98 [0.92-1.04],0.525074862888454,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CDH3,Cadherin-3,Inverse variance weighted,2,1.02 [0.96-1.09],0.528257396137204,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,2,1.02 [0.95-1.1],0.536157660615702,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CBLIF,Cobalamin binding intrinsic factor,Inverse variance weighted,2,1.03 [0.93-1.15],0.536358615723395,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ANXA10,Annexin A10,Inverse variance weighted,2,1.03 [0.94-1.12],0.543097595406736,trans
Chapter IX Diseases of the circulatory system,I9_PAD,THBD,Thrombomodulin,Inverse variance weighted,2,1.03 [0.95-1.11],0.54705199659078,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EDN1,Endothelin-1,Inverse variance weighted,2,1.03 [0.94-1.12],0.548047525531354,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.98 [0.92-1.05],0.548688433856344,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GAST,Gastrin,Inverse variance weighted,2,0.98 [0.92-1.05],0.549055391596111,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,2,1.02 [0.96-1.09],0.551809047019196,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MFGE8,Lactadherin,Inverse variance weighted,2,1.02 [0.96-1.09],0.565459810645932,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,2,0.98 [0.92-1.05],0.570945367664951,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ULBP2,UL16-binding protein 2,Inverse variance weighted,2,1.02 [0.95-1.09],0.573224659923394,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CA12,Carbonic anhydrase 12,Inverse variance weighted,2,0.98 [0.92-1.05],0.575709872803706,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,2,0.98 [0.93-1.04],0.576543817918542,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,2,1.02 [0.95-1.09],0.579878923583252,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LEP,Leptin,Inverse variance weighted,2,1.02 [0.95-1.09],0.584782219283585,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ASGR2,Asialoglycoprotein receptor 2,Inverse variance weighted,2,1.02 [0.95-1.08],0.590129899813959,trans
Chapter IX Diseases of the circulatory system,I9_PAD,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,2,1.02 [0.95-1.08],0.608163221030928,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,2,1.02 [0.96-1.08],0.611743195290337,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,2,1.04 [0.89-1.21],0.612405473933421,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,2,0.99 [0.93-1.04],0.612907473000915,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HSPA2,Heat shock-related 70 kDa protein 2,Inverse variance weighted,2,1.03 [0.91-1.17],0.615536622921094,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,2,1.02 [0.95-1.09],0.619379803017236,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TCN2,Transcobalamin-2,Inverse variance weighted,2,1.01 [0.96-1.07],0.621986535871172,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRTN3,Myeloblastin,Inverse variance weighted,2,1.02 [0.95-1.08],0.624938484895142,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PTPRB,Receptor-type tyrosine-protein phosphatase beta,Inverse variance weighted,2,1.04 [0.9-1.19],0.626602581831768,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SEPTIN8,Septin-8,Inverse variance weighted,2,1.02 [0.95-1.08],0.62893551252706,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.98 [0.92-1.05],0.631335470918906,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LCN15,Lipocalin-15,Inverse variance weighted,2,1.04 [0.9-1.19],0.634493630087581,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SIGLEC6,Sialic acid-binding Ig-like lectin 6,Inverse variance weighted,2,1.03 [0.91-1.18],0.636155508234227,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRND,Prion-like protein doppel,Inverse variance weighted,2,1.02 [0.95-1.08],0.636186411510257,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,2,1.02 [0.93-1.12],0.638316322203681,trans
Chapter IX Diseases of the circulatory system,I9_PAD,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,2,1.02 [0.94-1.1],0.641864321700272,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,Inverse variance weighted,2,1.02 [0.93-1.12],0.642335475678093,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD300A,CMRF35-like molecule 8,Inverse variance weighted,2,1.01 [0.95-1.08],0.643949591230276,trans
Chapter IX Diseases of the circulatory system,I9_PAD,THBS2,Thrombospondin-2,Inverse variance weighted,2,1.02 [0.95-1.09],0.644760966063474,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PSAP,Prosaposin,Inverse variance weighted,2,1.01 [0.95-1.08],0.65723751116154,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,2,0.99 [0.92-1.05],0.658882008908672,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.99 [0.92-1.05],0.661993517227578,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FSTL1,Follistatin-related protein 1,Inverse variance weighted,2,0.99 [0.92-1.05],0.670390964141941,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,2,0.99 [0.92-1.05],0.67222084164083,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MDK,Midkine,Inverse variance weighted,2,1.02 [0.93-1.12],0.673019527068397,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MMP10,Stromelysin-2,Inverse variance weighted,2,0.99 [0.93-1.05],0.673731151729309,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,0.98 [0.89-1.08],0.674830985639494,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,2,0.99 [0.93-1.05],0.675024584712965,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,2,0.99 [0.92-1.06],0.678373623185754,trans
Chapter IX Diseases of the circulatory system,I9_PAD,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,2,0.98 [0.91-1.06],0.6865993478439,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,2,1.02 [0.92-1.13],0.688993345290176,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CCL25,C-C motif chemokine 25,Inverse variance weighted,2,1.03 [0.9-1.18],0.693280514522176,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CNTN5,Contactin-5,Inverse variance weighted,2,0.99 [0.94-1.04],0.696664071812855,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,2,1.03 [0.88-1.2],0.700825768781224,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SLC39A14,Zinc transporter ZIP14,Inverse variance weighted,2,1.03 [0.88-1.2],0.702746031222634,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,2,0.98 [0.87-1.1],0.707103877558848,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,2,0.99 [0.93-1.05],0.719264124752792,trans
Chapter IX Diseases of the circulatory system,I9_PAD,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,1.01 [0.95-1.08],0.720413648375176,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD83,CD83 antigen,Inverse variance weighted,2,1.02 [0.93-1.11],0.720659871769798,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,2,0.99 [0.92-1.06],0.723448607462909,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.02 [0.91-1.14],0.732308355102995,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LMNB2,Lamin-B2,Inverse variance weighted,2,1.01 [0.95-1.08],0.733778451191608,trans
Chapter IX Diseases of the circulatory system,I9_PAD,KIF1C,Kinesin-like protein KIF1C,Inverse variance weighted,2,1.01 [0.94-1.09],0.734438206264946,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,2,0.98 [0.87-1.1],0.739778466261848,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.03 [0.87-1.21],0.744059259854712,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLGN,Calmegin,Inverse variance weighted,2,1.01 [0.95-1.07],0.747667800413505,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,2,1.01 [0.93-1.11],0.755564446094185,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,2,0.99 [0.93-1.06],0.758807703114083,trans
Chapter IX Diseases of the circulatory system,I9_PAD,BAMBI,BMP and activin membrane-bound inhibitor homolog,Inverse variance weighted,2,0.99 [0.92-1.06],0.763132719469932,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CALB2,Calretinin,Inverse variance weighted,2,1.01 [0.95-1.08],0.763594625681984,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD160,CD160 antigen,Inverse variance weighted,2,1.01 [0.93-1.11],0.767733789207544,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TFF2,Trefoil factor 2,Inverse variance weighted,2,1.01 [0.95-1.08],0.770271409375116,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,2,1.01 [0.94-1.09],0.77265678717298,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PKD1,Polycystin-1,Inverse variance weighted,2,0.99 [0.93-1.05],0.774042563850407,trans
Chapter IX Diseases of the circulatory system,I9_PAD,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,2,1.02 [0.88-1.19],0.776750227354336,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PHLDB1,Pleckstrin homology-like domain family B member 1,Inverse variance weighted,2,1.01 [0.94-1.08],0.78547245371488,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,2,1.01 [0.95-1.07],0.787920529957563,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,2,1.01 [0.94-1.08],0.788187676910508,trans
Chapter IX Diseases of the circulatory system,I9_PAD,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,2,0.99 [0.88-1.1],0.790036445598907,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,2,1.01 [0.92-1.12],0.793386560451557,trans
Chapter IX Diseases of the circulatory system,I9_PAD,AOC3,Membrane primary amine oxidase,Inverse variance weighted,2,0.98 [0.87-1.12],0.80048653568727,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FCN1,Ficolin-1,Inverse variance weighted,2,1.01 [0.95-1.07],0.80232417287403,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LRRC25,Leucine-rich repeat-containing protein 25,Inverse variance weighted,2,1.01 [0.95-1.07],0.803909538186024,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.99 [0.88-1.1],0.807677375218831,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,Inverse variance weighted,2,0.99 [0.9-1.09],0.811375534160185,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,2,0.99 [0.93-1.06],0.811903498387737,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,2,1.01 [0.94-1.08],0.813717033518072,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,2,0.99 [0.93-1.06],0.814675701106643,trans
Chapter IX Diseases of the circulatory system,I9_PAD,RSPO3,R-spondin-3,Inverse variance weighted,2,0.98 [0.84-1.15],0.822477188781774,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,2,1.01 [0.95-1.07],0.827079387834255,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ITGA11,Integrin alpha-11,Inverse variance weighted,2,1.01 [0.92-1.11],0.828122081511061,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CDH2,Cadherin-2,Inverse variance weighted,2,1.01 [0.95-1.07],0.828770950133883,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CFC1,Cryptic protein,Inverse variance weighted,2,1.01 [0.93-1.09],0.830525837835075,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,2,1.01 [0.92-1.11],0.839493620727556,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,1.01 [0.91-1.13],0.839522352792083,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FAM3D,Protein FAM3D,Inverse variance weighted,2,1.01 [0.95-1.06],0.840208559066307,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,2,1.01 [0.95-1.06],0.844810391165797,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",Inverse variance weighted,2,1.01 [0.94-1.08],0.849026780001187,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLMP,CXADR-like membrane protein,Inverse variance weighted,2,1.01 [0.95-1.07],0.849240775436552,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,2,0.99 [0.88-1.11],0.849795264412635,trans
Chapter IX Diseases of the circulatory system,I9_PAD,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,2,1.01 [0.94-1.07],0.857146395968215,trans
Chapter IX Diseases of the circulatory system,I9_PAD,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,2,1.01 [0.94-1.07],0.857198388212246,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MILR1,Allergin-1,Inverse variance weighted,2,1.01 [0.94-1.07],0.863132076060002,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,2,1 [0.96-1.06],0.866456003873943,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.01 [0.92-1.1],0.868114148642737,trans
Chapter IX Diseases of the circulatory system,I9_PAD,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,2,1.01 [0.94-1.07],0.870371514110059,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,2,0.99 [0.89-1.11],0.870926617579863,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,2,0.99 [0.91-1.08],0.872438172353439,trans
Chapter IX Diseases of the circulatory system,I9_PAD,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,2,1.01 [0.94-1.07],0.875181226638284,trans
Chapter IX Diseases of the circulatory system,I9_PAD,FGF5,Fibroblast growth factor 5,Inverse variance weighted,2,1 [0.95-1.06],0.877856991835369,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD99L2,CD99 antigen-like protein 2,Inverse variance weighted,2,0.99 [0.93-1.06],0.881072482468534,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CTSD,Cathepsin D,Inverse variance weighted,2,1 [0.93-1.06],0.886088134344635,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CKB,Creatine kinase B-type,Inverse variance weighted,2,0.99 [0.88-1.12],0.892785330609767,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,2,1 [0.94-1.07],0.90257618184509,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD55,Complement decay-accelerating factor,Inverse variance weighted,2,1 [0.94-1.07],0.918017290225197,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADM,Pro-adrenomedullin,Inverse variance weighted,2,1 [0.94-1.06],0.922538029358954,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,2,1 [0.95-1.06],0.922703129632445,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CX3CL1,Fractalkine,Inverse variance weighted,2,1 [0.91-1.09],0.924502952527057,trans
Chapter IX Diseases of the circulatory system,I9_PAD,STC2,Stanniocalcin-2,Inverse variance weighted,2,1 [0.94-1.06],0.930602900001851,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PTN,Pleiotrophin,Inverse variance weighted,2,1 [0.93-1.09],0.930658368850824,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1 [0.96-1.05],0.931985828194416,trans
Chapter IX Diseases of the circulatory system,I9_PAD,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,2,1 [0.95-1.06],0.948433485107565,trans
Chapter IX Diseases of the circulatory system,I9_PAD,DCN,Decorin,Inverse variance weighted,2,1 [0.94-1.07],0.949958298233318,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,2,1 [0.88-1.15],0.955694425836311,trans
Chapter IX Diseases of the circulatory system,I9_PAD,REG1A,Lithostathine-1-alpha,Inverse variance weighted,2,1 [0.87-1.16],0.955765327726791,trans
Chapter IX Diseases of the circulatory system,I9_PAD,B2M,Beta-2-microglobulin,Inverse variance weighted,2,1 [0.94-1.07],0.96453076152145,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,2,1 [0.93-1.07],0.967257374216662,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CLSTN2,Calsyntenin-2,Inverse variance weighted,2,1 [0.93-1.07],0.968703402026332,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL22,Interleukin-22,Inverse variance weighted,2,1 [0.94-1.07],0.969228011813106,trans
Chapter IX Diseases of the circulatory system,I9_PAD,MSLN,Mesothelin,Inverse variance weighted,2,1 [0.93-1.07],0.978301237974356,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,2,1 [0.94-1.06],0.980822983061701,trans
Chapter IX Diseases of the circulatory system,I9_PAD,PDCD1,Programmed cell death protein 1,Inverse variance weighted,2,1 [0.94-1.07],0.988173371366455,trans
Chapter IX Diseases of the circulatory system,I9_PAD,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,2,1 [0.94-1.06],0.990374645265651,trans
Chapter IX Diseases of the circulatory system,I9_PAD,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,2,1 [0.84-1.19],0.991964860119231,trans
Chapter IX Diseases of the circulatory system,I9_PAD,CD5,T-cell surface glycoprotein CD5,Inverse variance weighted,2,1 [0.94-1.07],0.997523901060811,trans
Chapter IX Diseases of the circulatory system,I9_PAD,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,2,1 [0.86-1.16],0.999331411163969,trans
